Graham Capital Management’s Medtronic MDT Stock Holding History

Graham Capital Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.61M	Sell	30,082 -8,560	-22%	-$820K	0.06%	222
2025 Q4	$3.71M	Sell	38,642 -8,600	-18%	-$835K	0.09%	147
2025 Q3	$4.5M	Buy	+47,242	New	+$4.34M	0.07%	122
2025 Q1	–	Sell	-16,548	Closed	-$1.32M	–	1422
2024 Q4	$1.32M	Buy	+16,548	New	+$1.43M	0.02%	418
2024 Q1	–	Sell	-83,279	Closed	-$6.86M	–	1209
2023 Q4	$6.86M	Sell	83,279 -55,272	-40%	-$4.21M	0.15%	95
2023 Q3	$10.9M	Buy	+138,551	New	+$11.6M	0.26%	68
2017 Q3	–	Sell	-13,600	Closed	-$1.21M	–	76
2017 Q2	$1.21M	Buy	+13,600	New	+$1.15M	0.03%	45
2015 Q1	–	Sell	-40,000	Closed	-$2.89M	–	142
2014 Q4	$2.89M	Buy	+40,000	New	+$2.78M	0.12%	98

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Graham Capital Management's MDT Position: Q1 2026 in Review

Graham Capital Management reduced its Medtronic (MDT) stake by 22% in Q1 2026, selling an estimated $820K and leaving 30,082 shares worth $2.61M. The position accounts for 0.06% of the portfolio, ranked #222.

Graham Capital Management first reported a position in MDT in Q4 2014 and has held it in 8 quarters since. The position peaked at $10.9M in Q3 2023. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Graham Capital Management held 30,082 shares of Medtronic worth $2.61M as of Q1 2026.
Graham Capital Management sold 8,560 Medtronic shares in Q1 2026, an estimated $820K.
Medtronic made up 0.06% of Graham Capital Management's portfolio in Q1 2026, its #222 holding.
Graham Capital Management first reported a position in Medtronic in Q4 2014 and has held it in 8 quarters since.
Graham Capital Management's Medtronic position peaked at $10.9M in Q3 2023.
2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Graham Capital Management's 13F filing for Q1 2026, filed 15 May 2026.